Maria Luisa Vargas

Dr. Maria Luisa Vargas

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1990 in General Pharmacology: The Vascular System
Verified
Journal Article
Closed access
MMMaría Victoria Milanés
María Victoria Milanés
JRJesús del Rio-García
Jesús del Rio-García
TFTeodomiro Fuente
Teodomiro Fuente
JMJ.Antonio Martínez
J.Antonio Martínez
MVMaria Luisa Vargas
Maria Luisa Vargas

18 June 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
RARocio Aguado
Rocio Aguado
JIJuan Irure-Ventura
Juan Irure-Ventura
MVMaria Luisa Vargas
Maria Luisa Vargas
GRGarbiñe Roy
Garbiñe Roy
Yvelise BarriosYvelise Barrios
Yvelise Barrios
Aurora Jurado RogerAurora Jurado Roger
Aurora Jurado Roger
Background/Objectives: Coeliac disease is an immune-mediated disorder of the gastrointestinal tract that may result in significant nutritional deficiencies. Effective management requires strict, lifelong adherence to a gluten-free diet. Both underdiagnosis and unnecessary dietary restrictions can adversely affect patients’ health and quality of life. To assess adherence to the current recommendations for the laboratory diagnosis of coeliac disease and promote evidence-based practices while reducing inter-laboratory variability, the Spanish Group on Autoimmunity of the Spanish Society of Immunology conducted a nationwide survey. Methods: A thirty-item survey was distributed to fifty autoimmune laboratories across Spain. Data were collected through a structured Excel-based questionnaire comprising multiple-choice items, which was distributed via email to the participating laboratories. It explored practices related to the diagnosis of coeliac disease in the general population and among at-risk groups as well as approaches to patient follow-up and demand management. Results: Thirty-five laboratories completed the electronic questionnaire. For the serological screening of coeliac disease, all the respondents reported using IgA anti-tissue transglutaminase (tTG-IgA) antibody testing together with total IgA measurement to assess IgA competence. However, consistent use of anti-endomysial antibody testing and HLA genotyping and adherence to pre-analytical recommendations for accurate interpretation of results were not uniform across centres. Conclusions: At the time these data were collected (the third trimester of 2021), the 2020 ESPGHAN guidelines for the diagnosis of coeliac disease in the paediatric population had not yet been fully implemented in most of the laboratories surveyed. For diagnosing adults, most laboratories adhered to local and European guidelines.

3 September 2024 in Clinical Immunology
Verified
Journal Article
Closed access
MSMarina Segura-Guerrero
Marina Segura-Guerrero
CSCarlos Saus
Carlos Saus
RRRoberto Gozalbo Rovira
Roberto Gozalbo Rovira
SPSheila Cabello Pelegrin
Sheila Cabello Pelegrin
MVMaria Luisa Vargas
Maria Luisa Vargas
MJMaria Rosa Julià
Maria Rosa Julià